Globus Financial Statements From 2010 to 2024

GMED Stock  USD 53.64  0.58  1.09%   
Globus Medical financial statements provide useful quarterly and yearly information to potential Globus Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Globus Medical financial statements helps investors assess Globus Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Globus Medical's valuation are summarized below:
Gross Profit
759.1 M
Profit Margin
0.0783
Market Capitalization
7.2 B
Enterprise Value Revenue
4.5812
Revenue
1.6 B
There are over one hundred nineteen available fundamental trends for Globus Medical, which can be analyzed over time and compared to other ratios. Investors should ensure to confirm all of Globus Medical's regular performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road.
Check Globus Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Globus main balance sheet or income statement drivers, such as Depreciation And Amortization of 152 M, Interest Expense of 21.1 M or Total Revenue of 1.6 B, as well as many exotic indicators such as Short Term Coverage Ratios of 17.38, Price Earnings Ratio of 25.09 or Price To Sales Ratio of 4.16. Globus financial statements analysis is a perfect complement when working with Globus Medical Valuation or Volatility modules.
  
This module can also supplement Globus Medical's financial leverage analysis and stock options assessment as well as various Globus Medical Technical models . Check out the analysis of Globus Medical Correlation against competitors.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

Globus Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding104.1 M114.6 M96.8 M
Slightly volatile
Total Assets5.3 B5.1 B1.6 B
Slightly volatile
Short and Long Term Debt Total546.4 M520.4 M74 M
Slightly volatile
Other Current Liabilities320.6 M305.3 M80.6 M
Slightly volatile
Total Current Liabilities412 M392.3 M129.7 M
Slightly volatile
Total Stockholder Equity4.2 BB1.4 B
Slightly volatile
Other Liabilities85.2 M81.1 M36.2 M
Slightly volatile
Property Plant And Equipment Net679.2 M646.9 M203.6 M
Slightly volatile
Current Deferred Revenue9.6 M18.4 M5.9 M
Slightly volatile
Retained Earnings764.6 M1.1 B699.7 M
Slightly volatile
Accounts Payable59.5 M56.7 M24.1 M
Slightly volatile
Cash490.7 M467.3 M188.5 M
Slightly volatile
Non Current Assets Total3.3 B3.2 B853.8 M
Slightly volatile
Other Assets111.3 M106 M50.2 M
Slightly volatile
Cash And Short Term Investments342.9 M517.8 M313.8 M
Slightly volatile
Net Receivables530.1 M504.9 M165.7 M
Slightly volatile
Common Stock Total Equity102.5 K115 K95.2 K
Slightly volatile
Liabilities And Stockholders Equity5.3 B5.1 B1.6 B
Slightly volatile
Non Current Liabilities Total730.6 M695.8 M122.1 M
Slightly volatile
Inventory890.5 M848.1 M231.3 M
Slightly volatile
Other Current Assets46.8 M44.6 M15.5 M
Slightly volatile
Other Stockholder EquityB2.9 B633.5 M
Slightly volatile
Total Liabilities1.1 B1.1 B251.8 M
Slightly volatile
Property Plant And Equipment Gross1.1 B1.1 B305.1 M
Slightly volatile
Total Current AssetsB1.9 B754.5 M
Slightly volatile
Short Term Debt11.4 M12 M21.7 M
Slightly volatile
Common Stock105.8 K136 K96.9 K
Slightly volatile
Property Plant Equipment146.5 M280.3 M143.9 M
Slightly volatile
Good Will1.5 B1.4 B277 M
Slightly volatile
Intangible Assets970.8 M924.6 M169.5 M
Slightly volatile
Net Tangible Assets981.4 M1.8 B889.4 M
Slightly volatile
Capital Surpluse761.9 M725.6 M345.7 M
Slightly volatile
Non Current Liabilities Other108.1 M102.9 M36 M
Slightly volatile
Long Term Investments71.7 M75.4 M174.9 M
Slightly volatile
Deferred Long Term Asset Charges17.1 M12.2 M22.1 M
Slightly volatile
Net Invested Capital4.6 B4.4 B1.6 B
Slightly volatile
Net Working Capital850.2 M1.5 B663.4 M
Slightly volatile
Capital Stock116 K136 K102.2 K
Slightly volatile
Capital Lease Obligations60 M103 M16.1 M
Slightly volatile

Globus Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization152 M144.7 M57.7 M
Slightly volatile
Total Revenue1.6 B1.6 B740.6 M
Slightly volatile
Gross Profit533.4 MB504.9 M
Slightly volatile
Other Operating Expenses1.4 B1.4 B582.9 M
Slightly volatile
Operating Income153.7 M133.1 M144.1 M
Slightly volatile
EBIT168.5 M256.3 M158.2 M
Slightly volatile
Research Development130.2 M124 M58.7 M
Slightly volatile
EBITDA221.9 M401 M209.3 M
Slightly volatile
Cost Of Revenue575.6 M548.2 M199.9 M
Slightly volatile
Total Operating Expenses859.4 M818.5 M383 M
Slightly volatile
Income Before Tax162.4 M165.4 M152.6 M
Slightly volatile
Net Income117.3 M122.9 M110.8 M
Slightly volatile
Income Tax Expense44.9 M42.5 M41.6 M
Very volatile
Selling General Administrative675.6 M643.4 M315.4 M
Slightly volatile
Net Income Applicable To Common Shares120.8 M218.7 M117.8 M
Slightly volatile
Net Income From Continuing Ops131.6 M122.9 M114.3 M
Slightly volatile
Tax Provision34.9 M42.5 M48.5 M
Slightly volatile
Interest Income21.1 M20.1 MM
Slightly volatile
Net Interest Income13.5 M20.1 M8.7 M
Slightly volatile
Reconciled Depreciation75.8 M144.7 M56.8 M
Slightly volatile

Globus Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation55.4 M52.7 M20.4 M
Slightly volatile
Free Cash Flow106.5 M165.2 M100 M
Slightly volatile
Begin Period Cash Flow139.2 M150.5 M132.5 M
Slightly volatile
Depreciation152 M144.7 M52.4 M
Slightly volatile
Other Non Cash Items102.4 M97.5 M28.8 M
Slightly volatile
Capital Expenditures49.9 M78.3 M47.8 M
Slightly volatile
Total Cash From Operating Activities156.4 M243.5 M147.9 M
Slightly volatile
Net Income117.5 M122.9 M111.1 M
Slightly volatile
End Period Cash Flow490.7 M467.3 M184.4 M
Slightly volatile
Issuance Of Capital Stock56.7 M73 M47.6 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Short Term Coverage Ratios17.3820.347530.0899
Pretty Stable
Price Earnings Ratio25.0949.045831.8304
Slightly volatile
Price To Sales Ratio4.163.84225.2527
Slightly volatile
Operating Cycle716682423
Slightly volatile
Price Book Value Ratio1.431.50743.4524
Slightly volatile
Days Of Payables Outstanding52.9437.734248.4502
Pretty Stable
Operating Cash Flow Per Share1.182.15321.4877
Slightly volatile
Price To Operating Cash Flows Ratio19.5824.749224.8572
Slightly volatile
Free Cash Flow Per Share0.811.4611.006
Slightly volatile
Price To Free Cash Flows Ratio50.4836.473948.1421
Pretty Stable
Pretax Profit Margin0.10.10540.2399
Slightly volatile
Inventory Turnover1.260.64631.1563
Slightly volatile
Ebt Per Ebit0.841.24221.0412
Pretty Stable
Payables Turnover6.429.67297.9225
Pretty Stable
Operating Profit Margin0.08060.08490.2299
Slightly volatile
Effective Tax Rate0.320.25710.2876
Slightly volatile
Company Equity Multiplier1.261.27221.1581
Pretty Stable
Long Term Debt To Capitalization0.09930.09450.0146
Slightly volatile
Cash Per Share2.584.57873.1795
Slightly volatile
Total Debt To Capitalization0.10.0970.0274
Slightly volatile
Return On Capital Employed0.02690.02840.1724
Slightly volatile
Debt Equity Ratio0.110.10740.0294
Slightly volatile
Ebit Per Revenue0.08060.08490.2299
Slightly volatile
Quick Ratio5.22.60654.764
Slightly volatile
Net Income Per E B T0.570.74290.7024
Slightly volatile
Cash Ratio2.231.1912.041
Slightly volatile
Cash Conversion Cycle677644375
Slightly volatile
Operating Cash Flow Sales Ratio0.180.15520.216
Very volatile
Days Of Inventory Outstanding593565351
Slightly volatile
Days Of Sales Outstanding12311772.0961
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.530.67850.6373
Pretty Stable
Cash Flow Coverage Ratios0.540.567124.9363
Slightly volatile
Price To Book Ratio1.431.50743.4524
Slightly volatile
Current Ratio7.284.88186.665
Slightly volatile
Fixed Asset Turnover2.32.42474.7484
Slightly volatile
Price Cash Flow Ratio19.5824.749224.8572
Slightly volatile
Enterprise Value Multiple13.015.159716.0352
Slightly volatile
Debt Ratio0.08860.08440.0249
Slightly volatile
Cash Flow To Debt Ratio0.540.567124.9363
Slightly volatile
Price Sales Ratio4.163.84225.2527
Slightly volatile
Return On Assets0.0230.02420.1101
Slightly volatile
Receivables Turnover6.093.10675.5762
Slightly volatile
Asset Turnover0.290.30840.6236
Slightly volatile
Net Profit Margin0.07440.07830.1681
Slightly volatile
Gross Profit Margin0.850.65050.7677
Slightly volatile
Price Fair Value1.431.50743.4524
Slightly volatile
Return On Equity0.02920.03070.1267
Slightly volatile

Globus Fundamental Market Drivers

Forward Price Earnings19.7628
Cash And Short Term Investments517.8 M

Globus Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Globus Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Globus Medical income statement, its balance sheet, and the statement of cash flows. Globus Medical investors use historical funamental indicators, such as Globus Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Globus Medical investors may use each financial statement separately, they are all related. The changes in Globus Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Globus Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Globus Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Globus Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Current Deferred Revenue18.4 M9.6 M
Total Revenue1.6 B1.6 B
Cost Of Revenue548.2 M575.6 M
Ebit Per Revenue 0.08  0.08 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out the analysis of Globus Medical Correlation against competitors.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Globus Stock analysis

When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.79)
Earnings Share
1.07
Revenue Per Share
13.87
Quarterly Revenue Growth
1.246
Return On Assets
0.0477
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.